Name: UMIN ID:
Unique ID issued by UMIN | UMIN000031117 |
---|---|
Receipt number | R000035538 |
Scientific Title | Multicenter, prospective interventional study to evaluate therapeutic effect of Afatinib in patients with advanced non-small cell lung cancer, EGFR mutation positive and brain metastasis |
Date of disclosure of the study information | 2018/02/03 |
Last modified on | 2023/02/07 21:57:06 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2018/02/02 15:07:37 | ||
2 | Update | 2018/04/16 20:09:52 | Recruitment status Anticipated trial start date |
|
3 | Update | 2020/08/11 22:44:14 | Date of IRB Last follow-up date Date trial data considered complete Date analysis concluded |
|
4 | Update | 2020/08/11 22:47:24 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
5 | Update | 2022/02/11 10:45:31 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
6 | Update | 2023/02/07 21:57:06 | Recruitment status Date of closure to data entry |